Q9976 — Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
Q9976 is a HCPCS Level II code for injection, ferric pyrophosphate citrate solution, 0.1 mg of iron. It belongs to the Temporary Codes section. It was terminated on December 31, 2015 and is not valid on new claims.
This code has been terminated
CMS terminated Q9976 on December 31, 2015. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for Q9976
- Long descriptor
- Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
- Short descriptor
- Inj ferric pyrophosphate cit
- Added
- July 1, 2015
- Terminated
- December 31, 2015
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to Q9976
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If Q9976 is not quite right, the correct code is very often within a few positions of it.
- Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study doseterminated
- Q9970Injection, ferric carboxymaltose, 1mgterminated
- Q9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)terminated
- Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)terminated
- Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgterminated
- Q9975Injection, factor viii fc fusion protein (recombinant), per iuterminated
- Q9977Compounded drug, not otherwise classifiedterminated
- Q9978Netupitant 300 mg and palonosetron 0.5 mgterminated
- Q9979Injection, alemtuzumab, 1 mgterminated
- Q9980Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mgterminated
- Q9981Rolapitant, oral, 1 mgterminated
- Q9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mgterminated
Questions about Q9976
What is HCPCS code Q9976?
Q9976 is a HCPCS Level II code for injection, ferric pyrophosphate citrate solution, 0.1 mg of iron. It sits in the Temporary Codes section.
Does Medicare cover Q9976?
The CMS HCPCS file marks Q9976 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is Q9976 still valid?
No. Q9976 was terminated on December 31, 2015 and should not be used on new claims.